Source - SMW
Numis today initiates coverage of Allergy Therapeutics PLC (LON:AGY) with a buy investment rating and price target of 37p.

Related Charts

Allergy Therapeutics (AGY)

+1.25p (+5.21%)
delayed 18:15PM